TNF and vasculitis: Use of tumor necrosis factor inhibitors (predominantly infliximab) and the interleukin-6 inhibitor tocilizumab has also been used with success for rheumatologic irAEs, but to our knowledge, they have not been used for CPI-vasculitis [3].